株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心臓バイオマーカー診断市場の分析

Analysis of the Cardiac Biomarker Diagnostics Market

発行 Frost & Sullivan 商品コード 341834
出版日 ページ情報 英文 116 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.25円で換算しております。
Back to Top
心臓バイオマーカー診断市場の分析 Analysis of the Cardiac Biomarker Diagnostics Market
出版日: 2015年09月30日 ページ情報: 英文 116 Pages
概要

心臓バイオマーカー診断は、米国ではまだニッチな、しかし将来有望な診断技術です。当局が個別化医療・診断を推奨する方向にあることから、大手企業は新たなバイオマーカーの研究・発見に多額の資金を投じて、他者との差別化を図ろうとしています。心臓病の有望者数が増えていることのほか、様々な臨床現場でポイントオブケア (POC) 方式にて利用できるようになったことが、市場成長の要因となっています。「患者中心の医療」を目指す動きが広がる中で、各社はより多様な現場で使える診断薬を開発して、市場での優位性を築こうとしています。

当レポートでは、心臓バイオマーカー診断の市場について分析し、技術上の特徴や基本的な市場構造、主な市場促進・阻害要因、全体的な市場動向の見通し、分野別の詳細動向、競争環境、他の診断技術との融合・連動の可能性、将来的な市場機会などについて調査・推計しております。

第1章 エグゼクティブ・サマリー

第2章 市場概要

  • 心臓診断薬産業の概要
  • 心臓バイオマーカー診断の概要
  • 市場の背景
  • 市場の背景:有病率
  • 心臓診断の概要
  • 市場概要:検査手順
  • 診断の利用可能性を左右する要因
  • 今後の医療動向の考察

第3章 競争戦略

  • 新たな市場戦略
  • 大手企業によるソリューション
  • 主要な事業提携:心臓バイオマーカーと体外診断 (IVD)
  • 心筋梗塞 (MI) 向けの新たなバイオマーカーと臨床上の利点

第4章 新規のバイオマーカー

  • LDT (自家製・未承認診断薬) :心臓診断における役割
  • その他の新たなバイオマーカー

第5章 市場促進・抑制要因:心臓バイオマーカー診断市場全体

  • 市場促進要因
  • 市場抑制要因

第6章 市場の予測と傾向:心臓バイオマーカー診断市場全体

  • 市場計測
  • 市場予測の前提条件と定義
  • 市場収益額の予測
  • 部門別の収益額シェア予測
  • 部門別のライフサイクル分析

第7章 競争環境

  • 市場シェア
  • 市場シェア分析
  • 全体的な市場シェア分析
  • 大手企業

第8章 ポイントオブケア検査 (POCT) 部門の分析

  • 市場計測
  • 市場収益額予測
  • POCT部門のシェア
  • 部門別市場シェアの分析
  • 競合製品の比較表
  • 米国市場の主なPOCT装置
  • 競合製品の分析

第9章 試験室向け製品部門の分析

  • 市場計測
  • 市場収益額予測
  • 市場収益額予測:疾患の種類別
  • 市場成長率:心臓疾患別
  • 製品ポートフォリオ
  • 価格動向とその予測
  • 部門別の市場シェア
  • 競合製品の比較表

第10章 心臓診断薬産業の概要:全体像

  • 心臓診断薬産業の概況
  • 事業提携の傾向:医療機器・診断薬

第11章 心臓画像診断

  • 産業概要
  • 産業概要:用途別
  • 新たな市場機会
  • 画像診断技術:様々な患者の診断における役割

第12章 心臓診断用の心電図 (ECG)

  • 産業概要
  • 心臓モニタリング機能:アプリケーション別
  • 新たな市場機会
  • ECG技術:様々な患者の診断における役割

第13章 市場機会

  • 市場機会:コンパニオン診断
  • デジタルヘルスと診断技術の一体化モデル:心臓診断の場合
  • 市場機会:画像診断と体外診断 (IVD) の融合
  • 市場機会:注目すべき主な企業

第14章 結論

第15章 付録

図表一覧

目次
Product Code: NF62-01-00-00-00

Emerging Biomarkers Disrupt and Spur Growth in the Heart Failure Segment

The cardiac biomarker diagnostics market is a niche but upcoming space in the United States. With regulations favoring personalized medicine and diagnostics, large companies are focusing their investment in researching and detecting new biomarkers to differentiate their products in this competitive market. In addition to growing prevalence rates that are driving this market, the increasing use of point-of-care testing devices at ambulatory and at clinical settings spurs this market in the region. The push towards a more patient centric and wholesome care places imaging companies that can provide a more comprehensive diagnostic product are at an advantage in this market.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Competitive Landscape
  • 4. Scope and Segmentation
  • 5. Key Questions This Study Will Answer
  • 6. Measurements
  • 7. CEO's Perspective
  • 8. Key Companies to Watch
  • 9. Executive Summary-3 Big Predictions

2. MARKET OVERVIEW

  • 1. Cardiac Diagnostics Industry Overview
  • 2. Cardiac Biomarkers Diagnostics Overview
  • 3. Market Background
  • 4. Market Background-Prevalence Rate
  • 5. Cardiac Diagnostics Overview
  • 6. Market Overview-Testing Procedure
  • 7. Factors Influencing Adoptability of Tests
  • 8. Defining Healthcare Trends in the Future

3. COMPETITIVE PLAYBOOK

  • 1. New Market Opportunities
  • 2. New Market Opportunities (continued)
  • 3. Solutions Provided by Top Companies
  • 4. Important Partnerships-Cardiac Biomarker IVD Diagnostics
  • 5. Emerging Biomarkers for MI and Clinical Strength

4. EMERGING BIOMARKERS

  • 1. LDTs-Role in Cardiac Diagnostics
  • 2. Other Emerging Biomarkers

5. DRIVER AND RESTRAINTS-TOTAL CARDIAC BIOMARKER DIAGNOSTICS MARKET

  • 1. Market Drivers
  • 2. Drivers Explained
  • 3. Drivers Explained (continued)
  • 4. Drivers Explained (continued)
  • 5. Market Restraints
  • 6. Restraints Explained
  • 7. Restraints Explained (continued)

6. FORECASTS AND TRENDS-TOTAL CARDIAC BIOMARKER DIAGNOSTICS MARKET

  • 1. Measurements
  • 2. Forecast Assumptions and Definitions
  • 3. Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Percent Revenue Breakdown by Segments
  • 6. Segment Lifecycle Analysis

7. COMPETITIVE ENVIRONMENT

  • 1. Market Share
  • 2. Market Share Analysis
  • 3. Overall Market Share Analysis
  • 4. Top Competitors
  • 5. Top Competitors (continued)
  • 6. Top Competitors (continued)
  • 7. Top Competitors (continued)
  • 8. Top Competitors (continued)

8. POCT SEGMENT ANALYSIS

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. POCT-Segment Share
  • 5. Segment Share Analysis
  • 6. Competitive Value Matrix
  • 7. Top POCT Devices in the US Market
  • 8. Competitive Product Analysis
  • 9. Competitive Product Analysis (continued)
  • 10. Competitive Product Analysis (continued)
  • 11. Competitive Product Analysis (continued)
  • 12. Competitive Product Analysis (continued)

9. LAB-BASED SEGMENT ANALYSIS

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Disease Type
  • 4. Growth Rate by Cardiac Disease
  • 5. Revenue Forecast Discussion
  • 6. Revenue Forecast Discussion (continued)
  • 7. Product Portfolio
  • 8. Product Portfolio (continued)
  • 9. Pricing Trends and Forecast
  • 10. Segment Share
  • 11. Segment Share Analysis
  • 12. Segment Share Analysis (continued)
  • 13. Competitive Value Matrix

10. THE FULL PICTURE-CARDIAC DIAGNOSTICS INDUSTRY OVERVIEW

  • 1. Cardiac Diagnostics Industry Overview
  • 2. Partnership Trends-Medical Device Diagnostics

11. CARDIAC IMAGING DIAGNOSTICS

  • 1. Industry Overview
  • 2. Industry Overview by Application
  • 3. New Market Opportunities
  • 4. Imaging Technology-Role in Patient Continuum

12. ECG IN CARDIAC DIAGNOSTICS

  • 1. Industry Overview
  • 2. Cardiac Monitoring by Application
  • 3. New Market Opportunities
  • 4. ECG Technology-Role in Patient Continuum

13. OPPORTUNITIES

  • 1. Opportunities-Companion Diagnostics
  • 2. Opportunities-Companion Diagnostics (continued)
  • 3. Opportunities-Companion Diagnostics (continued)
  • 4. Opportunities-Companion Diagnostics (continued)
  • 5. Digital Health and Diagnostics Inter Convergence Model-Cardiac Diagnostics
  • 6. Opportunity-Convergence of Imaging and IVD
  • 7. Opportunities-Key Companies to Watch

14. THE LAST WORD

  • 1. The Last Word-3 Big Predictions
  • 2. The Last Word-3 Big Predictions Discussion
  • 3. The Last Word-3 Big Predictions Discussion (continued)
  • 4. Legal Disclaimer

15. APPENDIX

  • 1. List of Others
  • 2. Methodology
  • 3. Learn More-Next Steps
  • 4. List of Exhibits
  • 5. List of Exhibits (continued)
  • 6. List of Exhibits (continued)
  • 7. List of Exhibits (continued)

List of Exhibits

  • Total Cardiac Biomarker Diagnostics Market: Competitive Landscape, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Industry Overview, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Market Overview, US, 2014
  • Cardiac Biomarker Diagnostics Prevalence Rate, US, 2009-2020
  • Total Cardiac Biomarker Diagnostics Market: Market Segmentation, US, 2014
  • Total Cardiac Biomarker Diagnostics Adoptability of Biomarker Tests, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Market Outlook, US, 2014 and 2024
  • Total Cardiac Biomarker Diagnostics Market: Game-changing Strategies, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Company Offerings, US, 2014
  • Total Cardiac Diagnostic Market: Notable Deals and Trends, US, 2011-2014
  • Net Improvement in Predicting of 30-day Mortality, Emerging Biomarkers, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: LDTs vs FDA-approved Tests, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Emerging Biomarkers, US,2014
  • Total Cardiac Biomarker Diagnostics Market: Key Market Drivers, US, 2015-2020
  • Total Cardiac Biomarker Diagnostics Market: Key Market Restraints, US, 2015-2020
  • Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Revenue Forecast, US, 2011-2021
  • Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2021
  • Total Cardiac Biomarker Diagnostics Market: Segment Lifecycle Analysis, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown, US, 2014
  • Total Cardiac Biomarkers Diagnostics Market: Company Market Share Analysis of Top 4 Participants, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: SWOT Analysis, US, 2014
  • POCT Segment: Market Engineering Measurements, US, 2014
  • POCT Segment: Revenue Forecast, US, 2011-2021
  • POCT Segment: Percent Revenue Breakdown, US, 2014
  • POCT Segment: Company Segment Share Analysis by Top 4 Participants, US, 2014
  • POCT Segment: Competitive Analysis, US, 2014
  • POCT Segment: Product Analysis, US, 2014
  • POCT Segment: Top 10 products, US, 2014
  • Lab-based Tests Segment: Market Engineering Measurements, US, 2014
  • Lab-based Tests Segment: Revenue Forecast, US, 2011-2021
  • Lab-based Tests Segment: Revenue Forecast by Disease Type, US, 2011-2021
  • Lab-based Tests Segment: Growth Rate by Cardiac Disease, US, 2011-2021
  • Lab-based Tests Segment: Product Analysis, US, 2014
  • Lab-based Tests Segment: Average Price, US, 2009-2021
  • Lab-based Tests Segment: Percent Revenue Breakdown, US, 2014
  • Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
  • Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
  • Lab-based Tests Segment: Competitive Analysis, US, 2014
  • Total Cardiac Diagnostics Industry: Industry Overview, US, 2014
  • Total Cardiac Diagnostic Industry: Notable Deals and Trends, US, 2011-2014
  • Total Cardiac Diagnostics Industry: Industry Overview, US, 2014
  • Total Cardiac Diagnostics Industry: Overview by Application, US, 2014
  • Total Cardiac Diagnostics Industry: Game-changing Strategies, US, 2014
  • Total Cardiac Diagnostics Industry: Patient Continuum, US, 2014
  • Total Cardiac Diagnostics Industry: ECG, US, 2014
  • Total Cardiac Monitoring Market: Market Segmentation, US, 2014
  • Total Cardiac Monitoring Market: Game-changing Strategies, US, 2014
  • Total Cardiac Diagnostics Industry: Patient Continuum, US, 2014
  • Total Cardiac Diagnostic Industry: Companies Pursuing CDx Opportunities, US, 2013-2015
  • Total Cardiac Diagnostic Industry: Pipeline Drugs for Each Cardiovascular Disease, US, 2013-2015
Back to Top